Related references
Note: Only part of the references are listed.Antimicrobial stewardship: A collaborative partnership between infection preventionists and health care epidemiologists
Julia Moody et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2012)
In Vitro Activity and Microbiological Efficacy of Tedizolid (TR-700) against Gram-Positive Clinical Isolates from a Phase 2 Study of Oral Tedizolid Phosphate (TR-701) in Patients with Complicated Skin and Skin Structure Infections
Philippe Prokocimer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Cethromycin versus Clarithromycin for Community-Acquired Pneumonia: Comparative Efficacy and Safety Outcomes from Two Double-Blinded, Randomized, Parallel-Group, Multicenter, Multinational Noninferiority Studies
Marci L. English et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Bactericidal Activity of ACH-702 against Nondividing and Biofilm Staphylococci
Steven D. Podos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Antimicrobial Activity of the Investigational Pleuromutilin Compound BC-3781 Tested against Gram-Positive Organisms Commonly Associated with Acute Bacterial Skin and Skin Structure Infections
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States
Ha T. Nguyen et al.
ANTIVIRAL RESEARCH (2012)
Totally Drug-Resistant Tuberculosis in India
Zarir F. Udwadia et al.
CLINICAL INFECTIOUS DISEASES (2012)
A Paradigm Shift in Drug Development for Treatment of Rare Multidrug-Resistant Gram-Negative Pathogens
Demissie Alemayehu et al.
CLINICAL INFECTIOUS DISEASES (2012)
Oritavancin: Mechanism of Action
George G. Zhanel et al.
CLINICAL INFECTIOUS DISEASES (2012)
Ceftaroline Fosamil: A Cephalosporin With Activity Against Methicillin-Resistant Staphylococcus Aureus
Henry Poon et al.
CLINICAL THERAPEUTICS (2012)
Improving known classes of antibiotics: an optimistic approach for the future
Karen Bush
CURRENT OPINION IN PHARMACOLOGY (2012)
Tuberculosis: The drug development pipeline at a glance
Baptiste Villemagne et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
George G. Zhanel et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
Policy Statement on Antimicrobial Stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS)
Neil Fishman et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2012)
In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci
Iciar Rodriguez-Avial et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Characterization of -lactamase and porin mutants of Enterobacteriaceae selected with ceftarolineavibactam (NXL104)
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Activity of delafloxacin against methicillin-resistant Staphylococcus aureus: resistance selection and characterization
Joan M. Remy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin
Toufeeq Imtiaz et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Outbreak of pulmonary infection caused by Klebsiella pneumoniae isolates harbouring b/aIMP-4 and b/aDHA-1 in a neonatal intensive care unit in China
Fangyou Yu et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Europe to boost development of new antimicrobial drugs
Tony Kirby
LANCET (2012)
Antibiotic Resistance Is Prevalent in an Isolated Cave Microbiome
Kirandeep Bhullar et al.
PLOS ONE (2012)
MDR, XDR, TDR tuberculosis: ominous progression
Zarir F. Udwadia
THORAX (2012)
Antibiotics in development targeting protein synthesis
Joyce A. Sutcliffe
ANTIMICROBIAL THERAPEUTICS REVIEWS: ANTIBIOTICS THAT TARGET THE RIBOSOME (2011)
Are pleuromutilin antibiotics finally fit for human use?
Rodger Novak
ANTIMICROBIAL THERAPEUTICS REVIEWS: ANTIBIOTICS THAT TARGET THE RIBOSOME (2011)
Contrasting Effects of Acidic pH on the Extracellular and Intracellular Activities of the Anti-Gram-Positive Fluoroquinolones Moxifloxacin and Delafloxacin against Staphylococcus aureus
Sandrine Lemaire et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Pharmacokinetics and Safety of Single and Multiple Doses of ACHN-490 Injection Administered Intravenously in Healthy Subjects
Robert T. Cass et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
In Vitro and In Vivo Profiles of ACH-702, an Isothiazoloquinolone, against Bacterial Pathogens
Michael J. Pucci et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
New antimicrobial agents on the horizon
Karen Bush et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Telavancin versus Vancomycin for HospitalAcquired Pneumonia due to Gram-positive Pathogens
Ethan Rubinstein et al.
CLINICAL INFECTIOUS DISEASES (2011)
Combating Antimicrobial Resistance: Policy Recommendations to Save Lives
Robert J. Guidos et al.
CLINICAL INFECTIOUS DISEASES (2011)
Antibiotic stewardship: overcoming implementation barriers
Abhijit M. Bal et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2011)
Proposals Seek to Reduce Resistance, Boost Development of New Antibiotics
Bridget M. Kuehn
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City
David Landman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study
Timothy R. Walsh et al.
LANCET INFECTIOUS DISEASES (2011)
Antimicrobial Stewardship
Shira Doron et al.
MAYO CLINIC PROCEEDINGS (2011)
Current Concepts in Antimicrobial Therapy Against Resistant Gram-Negative Organisms: Extended-Spectrum β-Lactamase Producing Enterobacteriaceae, Carbapenem-Resistant Enterobacteriaceae, and Multidrug-Resistant Pseudomonas aeruginosa
Souha S. Kanj et al.
MAYO CLINIC PROCEEDINGS (2011)
Antibiotic heterogeneity: from concept to practice
A. M. Bal et al.
ANTIMICROBIAL THERAPEUTICS REVIEWS (2010)
Cellular Pharmacokinetics of the Novel Biaryloxazolidinone Radezolid in Phagocytic Cells: Studies with Macrophages and Polymorphonuclear Neutrophils
Sandrine Lemaire et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Efficacy and Safety of Nemonoxacin versus Levofloxacin for Community-Acquired Pneumonia
Dirkie J. J. van Rensburg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Cellular Pharmacodynamics of the Novel Biaryloxazolidinone Radezolid: Studies with Infected Phagocytic and Nonphagocytic cells, Using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila
Sandrine Lemaire et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
In Vitro Antituberculosis Activities of ACH-702, a Novel Isothiazoloquinolone, against Quinolone-Susceptible and Quinolone-Resistant Isolates
Michael J. Pucci et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Resistance to Linezolid Is Mediated by the cfr Gene in the First Report of an Outbreak of Linezolid-Resistant Staphylococcus aureus
Gracia Morales et al.
CLINICAL INFECTIOUS DISEASES (2010)
Combating evolution with intelligent design: the neoglycoside ACHN-490
Eliana S. Armstrong et al.
CURRENT OPINION IN MICROBIOLOGY (2010)
Efflux Pumps of Gram-Negative Bacteria, a New Target for New Molecules
Jean-Marie Pages et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection
Elizabeth B. Hirsch et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Activity of chequerboard combinations of ceftaroline and NXL104 versus β-lactamase-producing Enterobacteriaceae
S. Mushtaq et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters
Shazad Mushtaq et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009)
David J. Farrell et al.
JOURNAL OF INFECTION (2010)
Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan
Abhijeet S. Nadkarni et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2009)
Promising Antituberculosis Activity of the Oxazolidinone PNU-100480 Relative to That of Linezolid in a Murine Model
K. N. Williams et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Probing the Differential Interactions of Quinazolinedione PD 0305970 and Quinolones with Gyrase and Topoisomerase IV
Xiao-Su Pan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2009)
In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains
K. J. Shaw et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
The epidemic of antibiotic-resistant infections: A call to action for the medical community from the Infectious Diseases Society of America
Brad Spellberg et al.
CLINICAL INFECTIOUS DISEASES (2008)
Waltzing transporters and 'the dance macabre' between humans and bacteria
Olga Lomovskaya et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome
Paola Guglierame et al.
BMC MICROBIOLOGY (2006)
The future should not look like the past
[Anonymous]
LANCET INFECTIOUS DISEASES (2006)
Share Paper
